GoHealth, Inc.

As of September 3, 2025, GoHealth, Inc. is in a bearish trend with weak strength, indicated by bearish daily moving averages and Bollinger Bands, while the stock has underperformed significantly over the past year with a return of -48.49% compared to the S&P 500's 17.14%.

As of August 7, 2025, GoHealth, Inc. is considered a risky investment due to its overvaluation, reflected in low P/E and EV to EBITDA ratios compared to peers, and a significant year-to-date stock decline of -63.7% versus the S&P 500's 12.22% return.

As of May 13, 2025, GoHealth, Inc. is considered an attractive investment due to its undervaluation, with a P/E ratio of 6 and an EV to EBITDA of 0.44, significantly lower than peers like Crawford & Co., despite a year-to-date return of -59.75% compared to the S&P 500's 2.44%.

As of June 6, 2025, GoHealth, Inc. is in a bearish trend with moderate strength, indicated by bearish MACD, Bollinger Bands, moving averages, and a year-to-date decline of 59.75%.

As of March 2022, the management team of GoHealth, Inc. includes CEO and Co-Founder Clinton Jones, along with Directors Rahm Emanuel, Joseph Flanagan, Jeremy Gelber, Miriam Tawil, and Alex Timm.

GoHealth, Inc. operates a health insurance marketplace that helps individuals find suitable health insurance plans. As of March 2025, it reported net sales of $221 million and a market cap of $62.45 million.

As of Jun 18, GoHealth, Inc. has a market capitalization of 62.45 million, with net sales of 834.26 million and a net profit of 4.25 million over the latest four quarters. The balance sheet shows shareholder's funds of 241.84 million and total assets of 1,492.44 million.